Tissue Regenix Group Share Price | |
---|---|
Price | 62.00 |
Bid | 61.00 |
Ask | 63.00 |
Change | 0.00 (0.00%) |
Volume | 31,577 |
Open | 62.00 |
High | 62.00 |
Low | 62.00 |
Prev. Close | 62.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 70.57m |
Market Capitalisation | £43.76m |
Market Size | 2,000 |
52 Week High | 71.50 |
52 Week High Date | 26-Feb-2024 |
52 Week Low | 49.00 |
52 Week Low Date | 03-Jul-2023 |
# Trades | 7 |
---|---|
Vol. Sold | 23,458 |
Sold Value | £14.35k |
Vol. Bought | 8,119 |
Bought Value | £5.09k |
PE Ratio | -32.4848 |
Earnings | -1.908585 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
23-May-24 | 16:27:26 | 62.50 | 119 | Buy* | 61.00 | 63.00 | 74.38 | O Ordinary |
23-May-24 | 12:25:19 | 61.40 | 500 | Sell* | 61.00 | 63.00 | 307.00 | O Ordinary |
23-May-24 | 11:32:03 | 61.16 | 10,000 | Sell* | 61.00 | 63.00 | 6,116 | O Ordinary |
23-May-24 | 11:06:49 | 62.68 | 8,000 | Buy* | 61.00 | 63.00 | 5,014 | O Ordinary |
23-May-24 | 08:57:10 | 61.12 | 9,039 | Sell* | 61.00 | 63.00 | 5,525 | O Ordinary |
23-May-24 | 08:53:05 | 61.40 | 719 | Sell* | 61.00 | 63.00 | 441.47 | O Ordinary |
23-May-24 | 08:05:08 | 61.325 | 3,200 | Sell* | 61.00 | 63.00 | 1,962 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
15-Sep-23 | 15-Sep-23 | Buy | Brian Phillips held the position of Independent Non-Executive Director at the time of this trade.Brian Phillips | 54.00 | GBX | 6,773 | 160,001 |
05-Apr-23 | 04-Apr-23 | Buy | David Cocke held the position of CFO at the time of this trade.David Cocke | 0.57 | GBX | 500,000 | 7,120,570 |
05-Apr-23 | 04-Apr-23 | Buy | David Cocke held the position of CFO at the time of this trade.David Cocke | 0.56 | GBX | 928,570 | 7,120,570 |
05-Apr-23 | 04-Apr-23 | Buy | Daniel Lee held the position of CEO at the time of this trade.Daniel Lee | 0.56 | GBX | 928,570 | 8,690,770 |
05-Apr-23 | 04-Apr-23 | Buy | Daniel Lee held the position of CEO at the time of this trade.Daniel Lee | 0.57 | GBX | 500,000 | 8,690,770 |
Tissue Regenix Group is a pioneering, international medical technology company, focusing on the development of regenerative products.